States told to ensure adherence to revised schedule
To this, the SII said they are doing their best to meet countrywide vaccine requirements.
Serum Institute of India CEO Adar Poonawalla has promised Chief Minister Uddhav Thackeray to deliver 15 million doses of Covishield to Maharashtra after May 20, said the state health minister
The health minister was holding a meeting with eight states that have been showing a higher number of daily cases, positivity rate and mortality
Delhi's Deputy Chief Minister Manish Sisodia accused the Centre of blocking supplies to the state.
Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to 10 crore and 7.8 crore doses respectively by August, official sources said on Wednesday The sources said the Union Health Ministry and the office of Drugs Controller General of India had sought from both the firms their production plan for June, July, August and September. The Hyderabad-based Bharat Biotech's indigenously developed Covaxin and Oxford-AstraZeneca's Covishield, being manufactured by the Pune-based Serum Institute of India, are currently being used in India's inoculation drive against coronavirus. Dr V Krishna Mohan, the Whole-time Director of Bharat Biotech, is learnt to have conveyed to the government that the production of Covaxin would be raised to 3.32 crore in July, and to 7.82 crore in August which will be maintained in September too. Similarly, Prakash Kum
For both companies, the pandemic presents a once-in-a-lifetime opportunity to earn hundreds of crores of rupees that could be ploughed back to fund further research and capacity expansion
Forget saving humanity, the unfolding tragedy has made it clear that India - even with the world's largest vaccine maker at its disposal - cannot save itself
Tamil Nadu, Haryana, Punjab, Bihar and North Eastern States are the states where vaccination wastage is 'quite high', the report said
A writ petition on Wednesday has been filed in the Bombay High Court seeking Z plus security for Serum Institute of India CEO Adar Poonawalla and his family
Here are the best of Business Standard's opinion pieces for Wednesday
Poonawalla's comments reveal the pitfalls of doing business in India
The Serum Institute of India will invest 240 million pounds in the UK to expand its vaccine business
Business Standard had reported in Monday's edition of the newspaper that the Centre had not yet placed fresh orders with the vaccine manufacturers. We stand corrected.
Poonawalla, who left for the UK recently, said in an interview that he was getting threatening calls from powerful people in India for delivering vaccine
The Serum Institute of India will invest 240 million pound in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs
A Maharashtra minister on Monday said Serum Institute of India's CEO Adar Poonawalla should lodge a police complaint in connection with the alleged threats that he has received
On his stay in the UK, the Serum Institute of India (SII) head said that he "had an excellent meeting" with all partners and stakeholders in that country
Adar Poonawalla told UK's The Times in an interview about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield
Adar Poonawalla said last week that the Serum Institute would be able to raise its monthly output to 100 million doses by July